Page 22 - IMO-2-2
P. 22

Innovative Medicines & Omics                                                 Pharmacotherapy of obesity



               doi: 10.1016/B978-0-12-817921-5.00001-1            in obesity and its determinants in Spain: What happens
                                                                  beyond  the obesity threshold?  Int  J  Health  Econ  Manag.
            20.  Chooi YC, Ding C, Magkos F. The epidemiology of obesity.
               Metabolism. 2019;92:6-10.                          2024;24(1):135-153.
               doi: 10.1016/J.METABOL.2018.09.005                 doi: 10.1007/s10754-023-09360-1
            21.  Son JW, Kim S. Comprehensive review of current and upcoming   33.  Kenney EL, Poole MK, McCulloch SM, et al. School-based
               anti-obesity drugs. Diabetes Metab J. 2020;44:802-818.  nutrition education programs alone are not cost effective for
                                                                  preventing childhood obesity: A microsimulation study. Am
               doi: 10.4093/dmj.2020.0258                         J Clin Nutr. 2024; 121:167-173.
            22.  Chacin M, Carrillo-Sierra S, Duran P, et al. Epidemiological      doi: 10.1016/J.AJCNUT.2024.11.006
               behavior of childhood obesity: A continental point of view.
               F1000Res. 2024;13:177.                          34.  Burki T. European Commission classifies obesity as a
                                                                  chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418.
               doi: 10.12688/f1000research.139123.1
                                                                  doi: 10.1016/S2213-8587(21)00145-5
            23.  Lin X, Li H. Obesity: Epidemiology, pathophysiology, and
               therapeutics. Front Endocrinol (Lausanne). 2021;12:706978.  35.  Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon
                                                                  Rectal Surg. 2011;24(4):205-210.
               doi: 10.3389/fendo.2021.706978
                                                                  doi: 10.1055/s-0031-1295684
            24.  Tsoi MF, Li HL, Feng Q, Cheung CL, Cheung TT, Cheung
               BMY. Prevalence of childhood obesity in the United States in   36.  Endalifer  ML,  Diress  G.  Epidemiology,  predisposing
               1999-2018: A 20-year analysis. Obes Facts. 2022;15(4):560-569.  factors, biomarkers, and prevention mechanism of obesity:
                                                                  A systematic review. J Obes. 2020;2020:6134362.
               doi: 10.1159/000524261
                                                                  doi: 10.1155/2020/6134362
            25.  Janssen F, Bardoutsos A, Vidra N. Obesity prevalence in the
               long-term future in 18 European countries and in the USA.   37.  Cawley J, Biener A, Meyerhoefer C,  et al. Direct medical
               Obes Facts. 2020;13(5):514-527.                    costs of obesity in the United States and the most populous
                                                                  states. J Manag Care Spec Pharm. 2021;27(3):354-366.
               doi: 10.1159/000511023
                                                                  doi: 10.18553/jmcp.2021.20410
            26.  Lingvay I, Cohen RV, Le Roux CW, Sumithran P. Obesity in
               adults. Lancet. 2024;404(10456):972-987.        38.  Von Lengerke T, Krauth C. Economic costs of adult obesity:
                                                                  A  review of recent European studies with a focus on
               doi: 10.1016/S0140-6736(24)01210-8
                                                                  subgroup-specific costs. Maturitas. 2011;69(3):220-229.
            27.  Purdy JC, Shatzel JJ. The hematologic consequences of
               obesity. Eur J Haematol. 2021;106(3):306-319.      doi: 10.1016/J.MATURITAS.2011.04.005
               doi: 10.1111/ejh.13560                          39.  D’Errico M, Pavlova M, Spandonaro F. The economic burden
                                                                  of obesity in Italy: A cost-of-illness study. Eur J Health Econ.
            28.  Marcus C, Danielsson P, Hagman E. Pediatric obesity-long-  2022;23(2):177-192.
               term consequences and effect of weight loss. J Intern Med.
               2022;292(6):870-891.                               doi: 10.1007/s10198-021-01358-1
               doi: 10.1111/joim.13547                         40.  Colditz GA. Economic costs of obesity.  Am J Clin Nutr.
                                                                  1992;55(2):503S-507S.
            29.  Mertens IL, Van Gaal LF. Overweight, obesity, and blood
               pressure: The effects of modest weight reduction. Obes Res.      doi: 10.1093/AJCN/55.2.503S
               2000;8(3):270-278.                              41.  Van Der Valk ES, Van Den Akker ELT, Savas M,  et al.
               doi: 10.1038/oby.2000.32                           A comprehensive diagnostic approach to detect underlying
                                                                  causes of obesity in adults. Obes Rev. 2019;20:795-804.
            30.  Halal CSE, Matijasevich A, Howe LD, Santos IS, Barros
               FC, Nunes ML. Short sleep duration in the first years of life      doi: 10.1111/obr.12836
               and obesity/overweight at age 4 years: A birth cohort study.   42.  El  Khoury  D,  Cuda  C,  Luhovyy  BL,  Anderson  GH.  Beta
               J Pediatr. 2016;168:99-103.e3.                     glucan: Health benefits in obesity and metabolic syndrome.
               doi: 10.1016/j.jpeds.2015.09.074                   J Nutr Metab. 2012;2012:28.
            31.  Shinde S, Tran AT, Jerry M, Lee CJ, Lilly E. Work loss among      doi: 10.1155/2012/851362
               privately insured employees with overweight and obesity in   43.  Zeng Q, Li N, Pan XF, Chen L, Pan A. Clinical management
               the United States. Obes Sci Pract. 2024;10:e775.   and  treatment  of  obesity  in  China.  Lancet Diabetes
               doi: 10.1002/osp4.775                              Endocrinol. 2021;9(6):393-405.
            32.  Raftopoulou A, Gil Trasfi J. Income-related inequality      doi: 10.1016/S2213-8587(21)00047-4


            Volume 2 Issue 2 (2025)                         16                               doi: 10.36922/imo.8316
   17   18   19   20   21   22   23   24   25   26   27